Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F15%3A10312714" target="_blank" >RIV/00216208:11160/15:10312714 - isvavai.cz</a>
Result on the web
<a href="http://www.jpp.krakow.pl/journal/archive/06_15/pdf/403_06_15_article.pdf" target="_blank" >http://www.jpp.krakow.pl/journal/archive/06_15/pdf/403_06_15_article.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin
Original language description
Endoglin, a transforming growth factor beta (TGF-beta) receptor type III, is co-expressed with endothelial nitric oxide synthase (eNOS) in aortic endothelium in atherosclerotic plaques of mice. Interestingly, atorvastatin (ATV) is able to increase both endoglin and eNOS expression and reduce plaque size beyond its lipid lowering effects but by unknown mechanisms. We hypothesized whether inflammation modulates ATV-dependent induction of endoglin and eNOS expression in vitro in endothelial cells and whether ATV-induced eNOS expression is regulated via endoglin. After treatment of human umbilical vein endothelial cells (HUVECs) with TNF-alpha, endoglin and eNOS protein expression was reduced, concomitantly with increased levels of cell surface VCAM-1 andsoluble endoglin, as determined by flow cytometry, Western blot and ELISA analyses. By contrast, ATV treatment increased endoglin and eNOS protein expression, while preventing TNF-alpha-mediated downregulation of endoglin and eNOS protein
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/EE2.3.30.0061" target="_blank" >EE2.3.30.0061: Increasing of the R&D capacity at Charles University through new positions for graduates of doctoral studies</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Physiology and Pharmacology
ISSN
0867-5910
e-ISSN
—
Volume of the periodical
66
Issue of the periodical within the volume
3
Country of publishing house
PL - POLAND
Number of pages
11
Pages from-to
403-413
UT code for WoS article
000357361400009
EID of the result in the Scopus database
2-s2.0-84930901347